« Back

Ocrelizumab

Fitted

Thursday March 30 2017 03:09 PM

First treatment licensed for primary progressive MS in the US

Ocrelizumab has been approved as a treatment for both relapsing and primary progressive MS in the US. It is the first licensed treatment for people with primary progressive MS. The decision was made by the US Food and Drug Administration (FDA).

In its latest trial results, researchers found that ocrelizumab reduced relapses, MRI activity and slowed progression in relapsing MS. It was also found to slow progression in primary progressive MS.

Ocrelizumab is currently being reviewed by the European Medicines Agency (EMA), the body responsible for drug licensing in Europe. A decision is expected later this year. The US decision came earlier because ocrelizumab was granted priority review status, which speeds up the licensing process. The EMA does not have a priority review system. 

MS Ireland understands that Ocrelizumab is expected to receive a license from the European Medicines Agency in August. The pharmaceutical company can then start the process for licensing and reimbursement in Ireland. MS Ireland will be working hard to try and make this medication available to people with MS in Ireland as soon as possible and we will share any updates as we get them.

Further reading

Author: MS Ireland

Tags: ocrelizumab, primaryprogressive, relapsing, ms, multiplesclerosis

Comments

Add a comment

Your email address will not be published and will only be used by MS Ireland to contact you should there be an issue with your comment.

Please read our policy on making comments. Basically, respect other people’s view, use appropriate language and be nice! Comments are published between 9am and 5pm, Monday to Friday.

We ask this question to ensure that you are a real person, and not a computer adding information automatically.

By commenting, you are adhering to our Terms of use / Privacy

Latest News

More news

What's hot

Tcd

Public Lecture

'MS Research Explored': Thursday, 30th November 2017 at 6pm, Trinity Biomedical Sciences Institute, Dublin 2. All welcome

Find out more

Events Calendar

» Our next Event

21 November 2017: Ongoing Group physiotherapist led exercise classes for people with MS

View all events

eNEWS SIGNUP

If you'd like to receive e-news updates from The Society please enter your email address below. If you want to know more about how we manage personal data then please see our privacy policy.

My local MSI

Map of MS Ireland's service areas South Mid West West Midlands South East North East North West North Dublin City and Fingal South West Dublin and Kildare South East Dublin and Wicklow